1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Splenic Mantle Cell Lymphoma: new trials by email Literature Review of Splenic Mantle Cell Lymphoma trials Research Report on Splenic Mantle Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Akt/ERK Inhibitor ONC201, Laboratory Biomarker Analysis, Pharmacological Study - Central Nervous System Lymphoma, Gastric Mantle Cell Lymphoma | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 16 | 2015-11-03 | 2022-04-04 |
Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
TIC10 compound (1)
M.D. Anderson Cancer Center (1)
United States (1)